Marlisa Miller, Editorial Intern

AnnMarie Hipsley, DPT, PhD, met with Ophthalmology Times Europe to discuss Ace Vision Group's microporation therapeutic technology, used to treat presbyopia.

Hundreds of previously-unknown genes could be vital for early detection and treatment.

Preliminary results indicate significant improvement for patients and ‘very good safety profile’